Join to View Full Profile
203 Arden Rd# 3Broomall, PA 19008
Phone+1 610-812-6279
Dr. Fox is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kevin Fox is an oncology specialist located in Philadelphia, PA, with subspecialties in breast cancer and hematologic oncology. He completed his medical education at Johns Hopkins University in 1981, followed by a residency in internal medicine and a fellowship in hematology and medical oncology. Dr. Fox is experienced in hematologic oncology and male breast cancer. His research includes publications on medication detection using wearable devices, breast cancer treatments, and the impact of COVID-19 on cardiovascular health. He has been involved in clinical trials focusing on vaccines for breast cancer and other cancer therapies. His accolades include recognition as one of the "Best Doctors" by Strathmere, multiple awards from Philadelphia Magazine and the University of Pennsylvania, and the Komen Philadelphia "Light of Life" Award.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1984 - 1987
Johns Hopkins UniversityResidency, Internal Medicine, 1981 - 1984- Johns Hopkins University School of MedicineClass of 1981
Certifications & Licensure
PA State Medical License 1984 - 2026
MD State Medical License 1981 - 1984
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- “Best Doctors” Strathmere
- Philadelphia Magazine’s “Top Docs”
- Forbes Honor Roll Forbes Magazime, 2017
- Join now to see all
Clinical Trials
- Multipeptide Vaccine for Advanced Breast Cancer Start of enrollment: 2007 Nov 01
- Multi-peptide Vaccine With Basilixumab for Breast Cancer Start of enrollment: 2012 Jun 01
- Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1) Start of enrollment: 2014 Jan 24
- Join now to see all
Publications & Presentations
PubMed
- Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium.Komal Jhaveri, Carey K Anders, Aditya Bardia, Manali Bhave, A Jo Chien
Clinical Breast Cancer. 2025-08-01 - 3 citationsDetection of Medication Taking Using a Wrist-Worn Commercially Available Wearable Device.Amy I Laughlin, Quy Cao, Richard Bryson, Virginia Haughey, Rashad Abdul-Salaam
JCO Clinical Cancer Informatics. 2023-09-01 - 5 citationsRuxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.Igor Makhlin, Nicholas P McAndrew, E Paul Wileyto, Amy S Clark, Robin Holmes
NPJ Breast Cancer. 2022-11-11
Press Mentions
Keeping Cancer ConqueredMay 20th, 2025
Professional Memberships
- Academy of Master Clinicians, University of Pennsylvania Health SystemCharter Member
- American Society of Clinical OncologyMember
- American Board of Internal MedicineChairman, SEP Committee on Recent Advances in Medical Oncology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
